•  
  •  
  •  
  •  

2025-10-02 10:20:43

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  Tarmat

Stock Report

  • Promoter Director acquires 10700 shares of Tarmat Limited through market purchase
  • Tarmat Limited JV wins order worth Rs. 139.48 crores
  • Tarmat Ltd consolidated Q2FY24 profit at Rs. 28.39 lakhs
  • Tarmat Ltd consolidated Q1 FY23 profit up at Rs. 1.66 crore
  • Tarmat Ltd consolidated Q4FY22 profit at Rs. 1.38 crore
  • TARMAT Ltd converts 170000 warrants into shares
  • TARMAT Ltd approves conversion of 38,02,576 warrants
  • Tarmat Ltd posts consolidated PAT of Rs. 86.17 lakhs in Q3 FY22

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024